Holen Sie sich die Stockscreener-App
0.66
0.15%
0.001
Handel nachbörslich:
.65
-0.01
-1.52%
Schlusskurs vom Vortag:
$0.659
Offen:
$0.64
24-Stunden-Volumen:
760.53K
Relative Volume:
0.48
Marktkapitalisierung:
$5.42M
Einnahmen:
$4.60M
Nettoeinkommen (Verlust:
$-7.33M
KGV:
0.0142
EPS:
46.49
Netto-Cashflow:
$-13.42M
1W Leistung:
+24.76%
1M Leistung:
+4.76%
6M Leistung:
-92.24%
1J Leistung:
-96.81%
1-Tages-Spanne:
$0.61
$0.67
1-Wochen-Bereich:
$0.45
$0.821
52-Wochen-Spanne:
$0.4359
$41.50
Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile
Firmenname
Tc Biopharm Holdings Plc Adr
Sektor
Branche
Telefon
01414337557
Adresse
MAXIM 1, HOLYTOWN
Vergleichen Sie TCBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TCBP
Tc Biopharm Holdings Plc Adr
|
0.66 | 5.42M | 4.60M | -7.33M | -13.42M | -5.0566 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tc Biopharm Holdings Plc Adr Aktie (TCBP) Neueste Nachrichten
TC BioPharm Advances Strategic Financial Initiative with New ADS Offering - TipRanks
TC BioPharm Announces Key Shareholder Meeting - TipRanks
TC Biopharm files $100M mixed securities shelf - TipRanks
TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks
TC BioPharm denies Nasdaq delisting rumors - Investing.com
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com India
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com
TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TCBP Announces Site Opening of Guys and St. Thomas Hospital - StockTitan
TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks
TC BioPharm to begin monkeypox treatment studies - Investing.com
TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle
TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News
Balance Sheet Insights: TC BioPharm (Holdings) plc ADR (TCBP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
TC BioPharm secures European patent for cell therapy - Investing.com India
TC BioPharm Regains Nasdaq Compliance - TipRanks
TC BioPharm meets Nasdaq equity requirement - Investing.com
TC Biopharm Unveils Pre-Funded Share Warrants - TipRanks
TC BioPharm secures $2 million in direct offering - Investing.com
TC Biopharm Announces Warrant Adjustment - TipRanks
TC Biopharm At Risk of Nasdaq Delisting - TipRanks
Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance
Apple Hospitality REIT Inc (APLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
TC BioPharm adjusts ADS to ordinary share ratio - Investing.com
TC BioPharm Shareholders Approve Key Resolutions - TipRanks
Is TC BioPharm (Holdings) plc ADR (TCBP) worth investing in despite its overvalued state? – US Post News - US Post News
TC BioPharm Reschedules 2024 AGM for July - TipRanks
TC Biopharm Board Members Resign Suddenly - TipRanks
Amkor Technology stock rated overweight by JPMorgan, sees strong packaging demand By Investing.com - Investing.com
TC BioPharm eyes expansion with CAR-NK technology LOI - Investing.com
TC BioPharm aims to slash cancer treatment costs By Investing.com - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug - Yahoo Finance
TC Biopharm (TCBP) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Tc Biopharm Holdings Plc Adr-Aktie (TCBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):